Pharmacological Activities of Ruthenium Complexes Related to Their NO Scavenging Properties
AbstractAngiogenesis is considered responsible for the growth of primary tumours and of their metastases. With the present study, the effects of three ruthenium compounds, potassiumchlorido (ethylendiamminotetraacetate)rutenate(III) (RuEDTA), sodium (bis-indazole)tetrachloro-ruthenate(III), Na[trans-RuCl4Ind2] (KP1339) and trans-imidazoledimethylsulphoxidetetrachloro-ruthenate (NAMI-A), are studied in vitro in models mimicking the angiogenic process. The ruthenium compounds reduced the production and the release of nitrosyls from either healthy macrophages and immortalized EA.hy926 endothelial cells. The effects of NAMI-A are qualitatively similar and sometimes quantitatively superior to those of RuEDTA and KP1339. NAMI-A reduces the production and release of nitric oxide (NO) by the EA.hy926 endothelial cells and correspondingly inhibits their invasive ability; it also strongly inhibits the angiogenesis in matrigel sponges implanted subcutaneously in healthy mice. Taken together, these data support the anti-angiogenic activity of the tested ruthenium compounds and they contribute to explain the selective activity of NAMI-A against solid tumour metastases, the tumour compartment on which angiogenesis is strongly involved. This anti-angiogenic effect may also contribute to the inhibition of the release of metastatic cells from the primary tumour. Investigations on the anti-angiogenic effects of NAMI-A at this level will increase knowledge of its pharmacological properties and it will give a further impulse to the development of this class of innovative metal-based drugs. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Castellarin, A.; Zorzet, S.; Bergamo, A.; Sava, G. Pharmacological Activities of Ruthenium Complexes Related to Their NO Scavenging Properties. Int. J. Mol. Sci. 2016, 17, 1254.
Castellarin A, Zorzet S, Bergamo A, Sava G. Pharmacological Activities of Ruthenium Complexes Related to Their NO Scavenging Properties. International Journal of Molecular Sciences. 2016; 17(8):1254.Chicago/Turabian Style
Castellarin, Anna; Zorzet, Sonia; Bergamo, Alberta; Sava, Gianni. 2016. "Pharmacological Activities of Ruthenium Complexes Related to Their NO Scavenging Properties." Int. J. Mol. Sci. 17, no. 8: 1254.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.